Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension

ConditionHypertension
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWeill Medical College of Cornell University

About this trial

The investigators propose an intervention that leverages the success of Community Healthcare Workers (CHWs) and telehealth to connect patients with severe hypertension from Emergency Department (ED) to primary care resources and to coach them to adopt evidence-based, practical lifestyle solutions relevant to urban living. The investigators have proposed this intervention as "Coaching and Navigation by Community Health Workers (CHWs) through Telehealth for High-risk Hypertension: CONNECT-HTN intervention. The investigators hypothesize that participants receiving the CONNECT-HTN intervention will have a lower likelihood of experiencing a major cardiac event compared with those referred to clinic-based care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Must be over the age of 18 years

Have an ED triage SBP ≥ 180 and/or DBP ≥ 110, with a repeat similar reading ≥30 minutes after triage

May have received treatment for elevated BP, but must have no evidence of end-organ damage (defined as dialysis dependence, acute stroke, acute coronary syndrome, acute kidney injury, or papilledema)

Have a functional status of either fully active (independent in daily activities) or mildly restricted but ambulatory and able to work (washing, toileting, dressing, feeding, mobility).

Disqualifiers

pregnant patients

terminally ill patients, as well as

those requiring admission to the hospital due to severe complications (other than deranged BP).

Trial design

Design model

Parallel

Treatments tested in this trial

  • CONNECT-HTN

    Behavioral

    We propose a multimodal intervention that leverages the success of CHWs and telehealth to connect patients with severe hypertension to primary care resources and coach them to adopt evidence-based, practical lifestyle solutions relevant to urban living. We call the intervention Coaching and Navigation by CHW through Telehealth for High-risk Hypertension or CONNECT-HTN. CONNECT HTN will add to the evidential basis for implementing many of the WHO Best Buys for Non-Communicable Disease (NCD) prevention and control, and will be the first study powered to measure substantive mortality and mortality outcomes in LMICs.

  • Standard ED management

    Other intervention

    During the Emergency Department (ED) admission, the participants in the control group will be provided a blood pressure measurement device and training to calculate their blood pressure at home. Standard ED management will be provided to these patients, followed by either discharge or admission for the management of hypertension.

Treatment groups

3,620 Participants
are divided into 2 treatment groups
Group A: Referral armActive comparator 1 intervention
Group B: T-CHW armExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Rate of Major Adverse Cardiac Events (MACE)

Major Adverse Cardiovascular Events (MACE) is a composite outcome including heart attack (myocardial infarction), stroke, heart failure, and cardiovascular death. The primary outcome will be assessed by comparing the cumulative incidence of MACE events between participants randomized to the CONNECT-HTN intervention arm and those randomized to referral to clinic-based care. MACE events will be identified through participant interviews, hospital record review, death certificates during the outcome collection team visit and verbal autopsy when required, and adjudicated using standardized criteria.

Time frame
Up to 36 months (during the outcome collection period)

Secondary outcomes

1

Blood Pressure (SBP/DBP) Over Time

Change in systolic and diastolic blood pressure over time, measured during blinded home visits using standardized oscillometric assessment. At each visit, three blood pressure readings will be obtained five minutes apart and averaged. Longitudinal blood pressure trajectories will be compared between trial arms.

Time frame
Every 6 months during follow-up (up to 36 months)
2

Outpatient Primary Care Follow-up

Proportion of participants who attend at least one outpatient primary care visit for hypertension management during the study period, assessed via participant report and/or available medical records during the outcome collection team visit

Time frame
Up to 36 months
3

Medication Adherence (MMAS-8 Score)

Medication adherence will be assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8), a validated self-report questionnaire commonly used in hypertension research. Scores range from 0 to 8, with higher scores indicating greater adherence. Adherence will be measured during blinded home visits and compared between study arms over time during the outcome collection team visit.

Time frame
Every 6 months during the 36-month follow-up period.

Other outcomes

1

Proportion of outcome measurement team visits completed

Proportion of scheduled outcome measurement team home visits successfully completed over the study period. Outcome measurement team, blinded to the study arm, will visit all patients at 6 month intervals to get their in home BP monitoring and collect information on patient's medication adherence, self-efficacy, and quality of life

Time frame
Once every 6 months during the 36 month follow-up period
2

Assessment of Participant Satisfaction using Telehealth Usability Questionnaire (Intervention group only)

Participant satisfaction with the CONNECT-HTN intervention will be assessed using the Telehealth Usability Questionnaire (TUQ), a seven-point Likert-scale instrument consisting of 21 questions administered to participants randomized to the intervention arm.

Time frame
6 months; 12 months; 18 months; 24 months; 30 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Weill Medical College of Cornell University

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator